IP Verse

Methods To Mobilize Progenitor/Stem Cells - EP2371361

The patent EP2371361 was granted to Genzyme on Aug 7, 2019. The application was originally filed on Jul 30, 2002 under application number EP10184509A. The patent is currently recorded with a legal status of "Revoked".

EP2371361

GENZYME
Application Number
EP10184509A
Filing Date
Jul 30, 2002
Status
Revoked
Aug 10, 2024
Grant Date
Aug 7, 2019
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions (7)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

ACCORD HEALTHCAREMay 7, 2020TER MEER STEINMEISTER & PARTNERADMISSIBLE
BETAPHARM ARZNEIMITTELMay 7, 2020HOPPEADMISSIBLE
SANDOZMay 7, 2020MAIWALDADMISSIBLE
STADA ARZNEIMITTELMay 7, 2020HAMM & WITTKOPPADMISSIBLE
ZENTIVAMay 7, 2020REDDIE & GROSEADMISSIBLE
TEVA PHARMACEUTICALSMay 6, 2020HAMM & WITTKOPPADMISSIBLE
GENERICS UK TRADING MYLANMay 4, 2020ELKINGTON AND FIFEADMISSIBLE

Patent Citations (44) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
DESCRIPTIONUS20010309196
DESCRIPTIONUS20020382155
DESCRIPTIONUS5021409
DESCRIPTIONUS5582823
DESCRIPTIONUS5583131
DESCRIPTIONUS5606053
DESCRIPTIONUS5612478
DESCRIPTIONUS5698546
DESCRIPTIONUS5756728
DESCRIPTIONUS5801281
DESCRIPTIONUS5817807
DESCRIPTIONUS6001826
DESCRIPTIONWO0002870
DESCRIPTIONWO0056729
DESCRIPTIONWO0144229
DESCRIPTIONWO02058653
DESCRIPTIONWO0222599
DESCRIPTIONWO0222600
DESCRIPTIONWO0226721
DESCRIPTIONWO0234745
OPPOSITIONEP1016413
OPPOSITIONEP1411918
OPPOSITIONUS10209001
OPPOSITIONUS7897590
OPPOSITIONWO0002870
OPPOSITIONWO0018885
OPPOSITIONWO0028987
OPPOSITIONWO0045814
OPPOSITIONWO0144229
OPPOSITIONWO03011277
OPPOSITIONWO9411027
OPPOSITIONWO9965507
SEARCHEP1016413
SEARCHUS5583131
SEARCHWO0002870
SEARCHWO0018885
SEARCHWO0028987
SEARCHWO0045814
SEARCHWO0056729
SEARCHWO0066112
SEARCHWO0144229
SEARCHWO0194420
SEARCHWO9950461
SEARCHWO9965507

Non-Patent Literature (NPL) Citations (146) New

NPL citations refer to non-patent references such as research papers, articles, or other publications cited during examination or opposition phases.

Citation PhaseReference Text
DESCRIPTION- ABI-YOUNES, S. ET AL., CIRC. RES., (2000), vol. 86, pages 131 - 138
DESCRIPTION- AIUTI, A. ET AL., J. EXP. MED., (1997), vol. 185, pages 111 - 120
DESCRIPTION- BLEUL, C. ET AL., J. EXP. MED., (1996), vol. 184, pages 1101 - 1109
DESCRIPTION- BROXMEYER ET AL., BLOOD, (2001), vol. 98, page 81
DESCRIPTION- BROXMEYER ET AL., BLOOD CELLS, MOLECULES AND DISEASES, (1998), vol. 24, pages 14 - 30
DESCRIPTION- BROXMEYER, H. E. ET AL., BLOOD CELLS, MOLECULES, AND DISEASES, (1998), vol. 24, no. 2, pages 14 - 30
DESCRIPTION- BROXMEYER, H. E. ET AL., EXP. HEMATOL., (1989), vol. 17, pages 455 - 459
DESCRIPTION- BROXMEYER, H. ET AL., EXP. HEMATOL., (1995), vol. 23, pages 335 - 340
DESCRIPTION- CROOP, J. M. ET AL., BONE MARROW TRANSPLANTATION, (2000), vol. 26, pages 1271 - 1279
DESCRIPTION- DALE, D., AM. J. OF HEMATOL., (1998), vol. 57, pages 7 - 15
DESCRIPTION- FEDYK, E. R. ET AL., J. LEUKOC. BIOL., (1999), vol. 66, pages 667 - 673
DESCRIPTION- GEAR, A. ET AL., BLOOD, (2001), vol. 97, pages 937 - 945
DESCRIPTION- GERLACH ET AL., J.BIOL. CHEM., (2001), vol. 276, pages 14153 - 14160
DESCRIPTION- GLASPY, J. ET AL., BLOOD, (1997), vol. 90, pages 2939 - 2951
DESCRIPTION- GLASPY, J. ET AL., CANCER CHEMOTHER. PHARMACOL., (1996), vol. 38, pages S53 - S57
DESCRIPTION- HODOHARA, K. ET AL., BLOOD, (2000), vol. 95, pages 769 - 775
DESCRIPTION- JACKSON, K. ET AL., J. CLIN. INVEST., (2001), vol. 107, pages 1395 - 1402
DESCRIPTION- JO, D-Y. ET AL., J. CLIN. INVEST., (2000), vol. 105, pages 101 - 111
DESCRIPTION- KING, A. ET AL., BLOOD, (2001), vol. 97, pages 1534 - 1542
DESCRIPTION- KOCHER, A. ET AL., NATURE MED., (2001), vol. 7, pages 430 - 436
DESCRIPTION- LILES ET AL., BLOOD, (2001), vol. 98, page 737A
DESCRIPTION- MAEKAWA, T. ET AL., INTERNAL MED., (2000), vol. 39, pages 90 - 100
DESCRIPTION- MAJKA, M. ET AL., BLOOD, (2000), vol. 96, pages 4142 - 4151
DESCRIPTION- MA, Q. ET AL., IMMUNITY, (1999), vol. 10, pages 463 - 471
DESCRIPTION- MA, Q. ET AL., PROC. NATL. ACAD. SCI USA, (1998), vol. 95, pages 9448 - 9453
DESCRIPTION- NAGASAWA, T. ET AL., INT. J HEMATOL., (2000), vol. 72, pages 408 - 411
DESCRIPTION- ORLIC, PNAS, (2001), vol. 98, pages 10344 - 10349
DESCRIPTION- PELED, A. ET AL., SCIENCE, (1999), vol. 283, pages 845 - 848
DESCRIPTION- PONOMARYOV, T. ET AL., J. CLIN. INVEST., (2000), vol. 106, pages 1331 - 1339
DESCRIPTION- PRUIJT, J. ET AL., CUR. OP. IN HEMATOL., (1999), vol. 6, pages 152 - 158
DESCRIPTION- Remington's Pharmaceutical Sciences, MACK PUBLISHING COMPANY
DESCRIPTION- RIVIERE, C. ET AL., BLOOD, (1999), vol. 95, pages 1511 - 1523
DESCRIPTION- ROSENFELD, C. ET AL., BONE MARROW TRANSPLARATATION, (1997), vol. 17, pages 179 - 183
DESCRIPTION- TACHIBANA, K. ET AL., NATURE, (1998), vol. 393, pages 591 - 594
DESCRIPTION- VADHAN-RAJ, S. ET AL., ANN. INTERN. MED., (1997), vol. 126, pages 673 - 81
DESCRIPTION- VIARDOT, A. ET AL., ANN. HEMATOL., (1998), vol. 77, pages 194 - 197
DESCRIPTION- VOERMANS, C., BLOOD, (2001), vol. 97, pages 799 - 804
DESCRIPTION- ZOU, Y-R. ET AL., NATURE, (1998), vol. 393, pages 595 - 599
EXAMINATION- C. W. Hendrix ET AL, "Pharmacokinetics and Safety of AMD-3100, a Novel Antagonist of the CXCR-4 Chemokine Receptor, in Human Volunteers", Antimicrobial agents and chemotherapy, (20000601), vol. 44, no. 6, doi:10.1128/AAC.44.6.1667-1673.2000, ISSN 0066-4804, pages 1667 - 1673, XP055086299
OPPOSITION- "10 Arzneimittelentwicklung und -prufung", Mutschler et al, Arzneimittelwirkungen, Wissenschaftliche Verlagsgesellschaft, (2001), pages 120 - 124, XP055699785
OPPOSITION- Anonymous, "AMD3100: Phase 1", bioCentury Week in Review, (20020715), page 1, XP055738795
OPPOSITION- Anonymous, "Aplastic Anaemia", Merck Manual Abstract, (201311), URL: https://www.merckmanuals.com, XP055699698
OPPOSITION- Anonymous, "Blood differential", Medicine Plus Extract, (2014), URL: https://medlineplus.gov/ency/article/003657.htm, XP055699739
OPPOSITION- BROXMEYER et al., "Abstract 3371: Interference of the SDF-1/CXCR4 axis in mice with AMD-3100 induces rapid high level mobilization of hematopoietic progenitor cells, and AMD-3100 acts synergistically with G-CSF and MIP-1a to mobilize progenitors", Blood, (20010000), vol. 98, no. 11, page 811a, XP055699678
OPPOSITION- BROXMEYER et al., "Abstract 34: AMD-3100, an antagonist of CXCR4, is a potent myeloid progenitor cell mobilizing agent in mouse strains differing in response to G-CSF induced mobilization and synergies with G-CSF in these mice to enhance mobilization", Experimental Haematology, (20020700), vol. 30, no. 6, page 45, XP055699679
OPPOSITION- Broxmeyer, Et Al, "Abstract 34: AMD-3100, an antagonist of CXCR4, is a potent myeloid progenitor cell mobilizing agent in mouse strains differing in response to G-CSF induced mobilization and synergies with G-CSF in these mice to enhance mobilization", Experimental Haematology, (20020701), vol. 30, no. 6, page 45, XP055699679
OPPOSITION- BROXMEYER et al., Blood, (20011207), vol. 98, no. 11, page 811a, XP055699678
OPPOSITION- BROXMEYER et al., "Experimental Haematology", International Society of Experimental Haematology meeting, (20020000), vol. 30, no. 6, XP055699679
OPPOSITION- BROXMEYER H E, "Regulation of hematopoiesis by chemokine family members.", INTERNATIONAL JOURNAL OF HEMATOLOGY., ELSEVIER SCIENCE PUBLISHERS., NL, NL, (20010701), vol. 74, no. 1, ISSN 0925-5710, pages 9 - 17, XP002606450
OPPOSITION- "Chapter 1, 7, 10, 11", Stefan Fraehauf et al, Novel Developments in Stem Cell Mobilization, Springer, (20120000), page 3, 4, 7, 8, 11, 12, 103, 104, 115, 201, 206, 209, 210, 221; 222, XP055699732
OPPOSITION- "Clinical Results", BioCentury, (20020715), vol. 10, no. 31, page 89
OPPOSITION- Clinical Results , Biocentury, vol. 10, no. 31, page B9
OPPOSITION- DATEMA, R. et al., "Antiviral efficacy in vivo of the anti-human immunodeficiency virus bicyclam SDZ SID 791 (JM 3100), an inhibitor of infectious cell entry", Antimicrob. Agents Chemother, (19960000), vol. 40, pages 750 - 754, XP000196373
OPPOSITION- EMA, "Mozobil 20 mg/ml solution for injection", ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS, (2019), pages 1 - 28, URL: https://www.ema.europa.eu/en/documents/product-information/mozobil-epar-product-information_en.pdf, XP055702626
OPPOSITION- EMA, "Mozobil plerizafor", European Medicines Agency - EPAR, (20140612), pages 1 - 3, URL: https://www.ema.europa.eu/, XP055699695
OPPOSITION- FAN, W. et al., "Deoxycytidine kinase promotes the migration and invasion of fibroblast-like synoviocytes from rheumatoid arthritis patients", Int. J. Clin. Exp. Pathol., (20130000), vol. 6, pages 2733 - 2744, XP055701582
OPPOSITION- FRUEHAUF et al., "A combination of granulocyte-colony-stimulating factor (G-CSF) and plerixafor mobilizes more primitive peripheral blood progenitor cells than G-CSF alone: results of a European phase II study", Cytotherapy, (20090000), vol. 11, no. 8, pages 992 - 1001, XP055699737
OPPOSITION- GERLACH et al., "Molecular interactions of cyclam and bicyclam non-peptide antagonists with the CXCR4 chemokine receptor", J. Biol. Chem, (20010427), vol. 276, no. 17, pages 14153 - 14160, XP002357019
OPPOSITION- LILES et al., "Augmented mobilization and collection of CD34+ hematopoietic cells from normal human volunteers stimulated with granulocyte-colony-stimulating factor by single-dose administration of AMD3100, a CXCR4 antagonist", Transfusion, (20050301), vol. 45, no. 3, pages 295 - 300, XP002606575
OPPOSITION- LILES et al., "Leukocytosis and mobilization of pluripotent hematopoietic progenitor cells in healthy volunteers induced by single dose administration of AMD-3100, a CXCR4 antagonist", Blood, (20010000), vol. 98, no. 11, page 737a, XP055699681
OPPOSITION- Liles, Et Al, "Leukocytosis and mobilization of pluripotent hematopoietic progenitor cells in healthy volunteers induced by single dose administration of AMD-3100, a CXCR4 antagonist", Blood, (20010101), vol. 98, no. 11, page 737a, XP055699681
OPPOSITION- LILES, W.C. et al., "Abstract 3071 Leukocytosis and Mobilization of Pluripotent Hematopietic Progenitor Cells in Healthy Volunteers Induced by Single Dose Administration of AMD-3100, a CXCR4 Antagonist", Stem Cells Mobilization, 737a, (20010000), XP055701604
OPPOSITION- LILIES et al., Blood, (20011211), vol. 98, no. 11, page 737a, XP055699681
OPPOSITION- "L-Lysyl-glycol-L-varyl-L-seryl...", Thomsom Pharma, (20010523), Database accession no. 303892, XP055699803
OPPOSITION- "L-Seryl-L-leucyl...", Thomsom Pharma, (19940916), Database accession no. 212501, XP055699800
OPPOSITION- Medicine Plus Extract- Blood differential, URL: http://www.nlm.nih.gov/medlineplus/ency/article/003657.htm, XP055699739
OPPOSITION- MESTAS et al., "Of mice and not men: differences between mouse and human immunology", The Journal of Immunology, (20040301), vol. 172, no. 5, pages 2731 - 2738, XP002427631
OPPOSITION- PELUS et al., "The CXCR4 agonist peptide, CTCE-0021, rapidly mobilizes polymorphonuclear neutrophils and hematopoietic progenitor cells into peripheral blood and synergizes with granulocyte colony-stimulating factor", Experimental Hematology, (20050301), vol. 33, no. 3, pages 295 - 307, XP027605228
OPPOSITION- Thomsom Pharma, (20020531), Database accession no. 251353, XP055699795
OPPOSITION- VAN OS et al., "The CXCR4 receptor antagonist AMD3100 does not prevent homing and engraftment of murine syngeneic bone marrow stem cells", Blood, San Francisco, California, USA, (20001116), vol. 96, no. 11, page 308b, XP008081153
OPPOSITION- WONG et al., "A Stromal Cell Derived Factor 1 (SDF-1) Agonist StimulatesNeutrophil Mobilization in Normal Humans after Subcutaneous Injection", Blood (ASH Annual Meeting Abstracts), vol. 106, no. 11, (20051116), URL: https://ashpublications.org/blood/article/106/11/4262/122934/A-Stromal-Cell-Derived-Factor-1-SDF-1-Agonist, XP055699694
OPPOSITION- VOLIN et al., Biochem , Biophys. Res. Commun., (19980106), vol. 242, no. 1, pages 46 - 53, XP029094711
OPPOSITION- BROXMEYER et al., "Regulation of Hematopoiesis by Chemokine Family Members", International Journal of Hematology, (20010701), vol. 74, no. 1, pages 9 - 17, XP036519282
OPPOSITION- Broxmeyer H. et al, "Regulation of Hematopoiesis by Chemokine Family Members", International journal of Hematology, (20010701), vol. 74, no. 1, pages 9 - 17, XP036519282
OPPOSITION- Viadot A., "The human immunodeficiency virus (HIV)-type 1 coreceptor CXCR-4 (fusin) is preferentially expressed on the more immature CD34+ hematopoietic stem cells", Ann. Hematol, (19981100), vol. 77, no. 4, doi:10.1007/s002770050442, pages 193 - 197, XP000866301
OPPOSITION- VIARDOT A., ET AL., "THE HUMAN IMMUNODEFICIENCY VIRUS (HIV)-TYPE 1 CORECEPTOR CXCR-4 (FUSIN) IS PREFERENTIALLY EXPRESSED ON THE MORE IMMATURE CD34+ HEMATOPOIETIC STEM CELLS.", ANNALS OF HEMATOLOGY, BERLIN, DE, DE, (19981101), vol. 77., no. 05., doi:10.1007/s002770050442, ISSN 0939-5555, pages 193 - 197., XP000866301
OPPOSITION- VIARDOT, A. et al., "The human immunodeficiency virus (HIV)-type 1 coreceptor CXCR-4 (fusin) is preferentially expressed on the more immature CD 34+ hematopoietic stem cells", Ann. Hematol., (19980000), vol. 77, doi:10.1007/s002770050442, pages 193 - 197, XP000866301
OPPOSITION- VIARDOT et al., Ann. Hematol., (19980000), vol. 77, pages 193 - 197, XP000866301
OPPOSITION- VIARDOT et al., "The human immunodeficiency virus (HIV)-type 1 coreceptor CXCR-4 (fusin) is preferentially expressed on the more immature CD34+ hematopoietic stem cells", Ann. Hemato, (19980101), vol. 77, no. 5, pages 193 - 197, XP000866301
OPPOSITION- SHEWACH DS et al., "Affinity of the antiviral enantiomers of oxathiolane cytosine nucleosides for human 2'-deoxycytidine kinase", Biochem Pharmacol., (19930406), vol. 45, no. 7, doi:10.1016/0006-2952(93)90058-5, pages 1540 - 3, XP025541087
OPPOSITION- VAN ROMPAY, A.R. et al., "Substrate specificity and phosphorylation of antiviral and anticancer nucleoside analogues by human deoxyribonucleoside kinases and ribonucleoside kinases", Pharmacol. Ther., (20031100), vol. 100, no. 2, pages 119 - 139, XP055701581
OPPOSITION- MA Q. et al., "The Chemokine Receptor CXCR4 Is Required for the Retention of B Lineage and Granulocytic Precursors within the Bone Marrow Microenvironment", Immunity, (19990400), vol. 10, no. 4, pages 463 - 471, XP002453198
OPPOSITION- DUARTE et al., "Plerixafor plus granulocyte CSF can mobilize hematopoietic stem cells from multiple myeloma and lymphoma patients failing previous mobilization attempts: EU compassionate use data", Bone Marrow Transplantation, (20110101), vol. 46, no. 1, pages 52 - 58, XP055699701
OPPOSITION- PETIT et al., "G-CSF induces stem cell mobilization by decreasing bone marrow SDF-1 and up-regulating CXCR4", Nature Immunology, (20020701), vol. 3, no. 7, pages 687 - 694, XP002289815
OPPOSITION- DONZELLA et al., "AMD-3100, a small molecule inhibitor of HIV entry via the CXCR4 co- receptor", Nature Medicine, (19980101), vol. 4, no. 1, pages 72 - 77, XP000886577
OPPOSITION- DONZELLA et al., Nature Medicine, (19980000), vol. 4, no. 1, pages 72 - 77, XP000886577
OPPOSITION- DONZELLA G A; ET AL, "AMD3100, A SMALL MOLECULE INHIBITOR OF HIV-1 ENTRY VIA THE CXCR4 CO-RECEPTOR", Nature Medicine, (19980101), vol. 4, no. 1, pages 72 - 77, XP000886577
OPPOSITION- DONZELLA G. A., ET AL., "AMD3100, A SMALL MOLECULE INHIBITOR OF HIV-1 ENTRY VIA THE CXCR4 CO-RECEPTOR.", Nature Medicine, Nature Pub. Co., New York, New York, (19980101), vol. 04., no. 01., doi:10.1038/nm0198-072, ISSN 1078-8956, pages 72 - 77., XP000886577
OPPOSITION- CROOP et al., Curr Opin Haematol, (20000000), vol. 26, pages 1271 - 1279, XP055097594
OPPOSITION- CROOP et al., "Large-scale mobilization and isolation of CD 34+ cells from normal donors", Bone Marrow Trans, (20000000), vol. 26, doi:10.1038/sj.bmt.1702720, pages 1271 - 1279, XP055097594
OPPOSITION- YU et al., "The predictive value of white cell or CD34+ cell count in the peripheral blood for timing apheresis and maximizing yield", Transfusion, (19990500), vol. 39, no. 5, pages 442 - 450, XP055699706
OPPOSITION- GUPTA et al., "Chemokine Receptors in Human Endothelial Cells : FUNCTIONAL EXPRESSION OF CXCR4 AND ITS TRANSCRIPTIONAL REGULATION BY INFLAMMATORY CYTOKINES", J. Biol. Chem., (19980213), vol. 273, no. 7, pages 4282 - 4287, XP002922249
OPPOSITION- Aiuti A. et al, "THE CHEMOKINE SDF-1 IS A CHEMOATTRACTANT FOR HUMAN CD34+ HEMATOPOIETIC PROGENITOR CELLS AND PROVIDES A NEW MECHANISM TO EXPLAIN THE MOBILIZATION OF CD34+ PROGENITORS TO PERIPHERAL BLOOD", J. Exp. Med., (19970101), vol. 185, no. 1, pages 111 - 120, XP000866066
OPPOSITION- AIUTI A. et al, "THE CHEMOKINE SDF-1 IS A CHEMOATTRACTANT FOR HUMAN CD34+ HEMATOPOIETIC PROGENITOR CELLS AND PROVIDES A NEW MECHANISM TO EXPLAIN THE MOBILIZATION OF CD34+ PROGENITORS TO PERIPHERAL BLOOD", The Journal of Experimental Medicine, (19970101), vol. 185, no. 1, pages 111 - 120, XP000866066
OPPOSITION- AIUTI A., ET AL., "THE CHEMOKINE SDF-1 IS A CHEMOATTRACTANT FOR HUMAN CD34+ HEMATOPOIETIC PROGENITOR CELLS AND PROVIDES A NEW MECHANISM TO EXPLAIN THE MOBILIZATION OF CD34+ PROGENITORS TO PERIPHERAL BLOOD.", The Journal of Experimental Medicine, Rockefeller University Press, US, US, (19970101), vol. 185., no. 01., doi:10.1084/jem.185.1.111, ISSN 0022-1007, pages 111 - 120., XP000866066
OPPOSITION- AIUTI et al., J. Exp. Med., (19970000), vol. 185, no. 1, pages 111 - 120, XP000866066
OPPOSITION- AIUTI et al., "THE CHEMOKINE SDF-1 IS A CHEMOATTRACTANT FOR HUMAN CD34+ HEMATOPOIETIC PROGENITOR CELLS AND PROVIDES A NEW MECHANISM TO EXPLAIN THE MOBILIZATION OF CD34+ PROGENITORS TO PERIPHERAL BLOOD", J. Exp. Med., (19970101), vol. 185, no. 1, pages 111 - 120, XP000866066
OPPOSITION- SCHOLS D et al., "Inhibition of T-tropic HIV strains by selective antagonization of the chemokine receptor CXCR4", J Exp Med., (19971020), vol. 186, no. 8, doi:10.1084/jem.186.8.1383, pages 1383 - 8, XP002932483
OPPOSITION- BROXMEYER et al., "RAPID MOBILIZATION OF MURINE AND HUMAN HEMATOPOIETIC STEM AND PROGENITOR CELLS WITH AMD3100, A CXCR4 ANTAGONIST", J. Exp. Med., (20050418), vol. 201, no. 8, pages 1307 - 1318, XP009076434
OPPOSITION- GAZITT J. HAEMATOTHER, Stem Cell Res., vol. 10, pages 229 - 236, XP055699685
OPPOSITION- GAZITT Y, "Recent developments in the regulation of peripheral blood stem cell mobilization and engraftment by cytokines, chemokines, and adhesion molecules", J. Haematother. Stem Cell Res., (20010709), vol. 10, no. 2, pages 229 - 236, XP055699685
OPPOSITION- Olavarria E, Et Al, "Selection and use of chemotherapy with hematopoietic growth factors for mobilization of peripheral blood progenitor cells", Current opinion in hematology, (20000501), vol. 7, no. 3, doi:10.1097/00062752-200005000-00011, pages 191 - 196, XP055699788
OPPOSITION- Olavarria E. et al, "Selection and use of chemotherapy with hematopoietic growth factors for mobilization of peripheral blood progenitor cells", Current opinion in hematology, (200005), vol. 7, no. 3, pages 191 - 196, XP055699788
OPPOSITION- OLAVARRIA et al., Curr Opin Haematol, (20000000), vol. 7, pages 19 1 - 196, XP055699788
OPPOSITION- OLAVARRIA et al., "Selection and use of chemotherapy with hematopoietic growth factors for mobilization of peripheral blood progenitor cells", Curr Opin Haematol, (20000501), vol. 7, no. 3, pages 191 - 196, XP055699788
OPPOSITION- MOEHLE R, ET AL., "REGULATION OF TRANSENDOTHELIAL MIGRATION OF HEMATOPOIETIC PROGENITOR CELLS", Annals of the New York Academy of Sciences, New York Academy of Sciences., US, US, (19990430), vol. 872, doi:10.1111/j.1749-6632.1999.tb08463.x, ISSN 0077-8923, pages 176 - 186, XP009032435
OPPOSITION- R Möhle et al, "Regulation of transendothelial migration of hematopoietic progenitor cells", Annals of the New York Academy of Sciences, (19990430), vol. 872, no. 1, pages 176 - 186, XP009032435
OPPOSITION- VIARD I et al., "Inhibition of toxic epidermal necrolysis by blockade of CD 95 with human intravenous immunoglobulin", Science, (19980000), vol. 282, no. 5388, doi:10.1126/science.282.5388.490, pages 490 - 3, XP002119663
OPPOSITION- Peled A. et al, "Dependence of human stem cell engraftment and repopulation of NOD/SCID mice on CXCR4", Science, (19990205), vol. 283, pages 845 - 848, XP002180064
OPPOSITION- PELED A. et al, "Dependence of human stem cell engraftment and repopulation of NOD/SCID mice on CXCR4", Science, (19990205), vol. 283, pages 845 - 848, XP002180064
OPPOSITION- PELED A. ET AL., "Dependence of human stem cell engraftment and repopulation of NOD/SCID mice on CXCR4.", Science, American Association for the Advancement of Science, US, US, (19990205), vol. 283, doi:10.1126/science.283.5403.845, ISSN 0036-8075, pages 845 - 848, XP002180064
OPPOSITION- PELED et al., "Dependence of human stem cell engraftment and repopulation of NOD/SCID mice on CXCR4", Science, (19990205), vol. 283, pages 845 - 848, XP002180064
OPPOSITION- PELED et al., Science, (19990000), vol. 283, pages 845 - 848, XP002180064
OPPOSITION- Hendrix, Craig W., "Pharmacokinetics and Safety of AMD-3100, a Novel Antagonist of the CXCR-4 Chemokine Receptor, in Human Volunteers", Antimicrobial agents and chemotherapy, (20000601), vol. 44, no. 6, pages 1667 - 1673, XP055086299
OPPOSITION- HENDRIX CW et al., "Pharmacokinetics and safety of AMD-3100, a novel antagonist of the CXCR-4 chemokine receptor, in human volunteers", Antimicrob Agents Chemother, (20000600), vol. 44, no. 6, doi:10.1128/AAC.44.6.1667-1673.2000, pages 1667 - 73, XP055086299
OPPOSITION- HENDRIX et al., Antimicrob. Agents Chemother, (20000000), pages 1667 - 1673, XP055086299
OPPOSITION- HENDRIX et al., "Pharmacokinetics and safety of AMD-3100, a novel antagonist of the CXCR-4 chemokine receptor, in human volunteers", Antimicrob. Agents Chemother., (20000000), vol. 44, no. 6, doi:10.1128/AAC.44.6.1667-1673.2000, pages 1667 - 1673, XP055086299
OPPOSITION- HENDRIX et al., "Pharmacokinetics and Safety of AMD-3100, a Novel Antagonist of the CXCR-4 Chemokine Receptor, in Human Volunteers", Antimicrobial Agents & Chemotherapy, (20000601), vol. 44, no. 6, pages 1667 - 1673, XP055086299
OPPOSITION- HENRIX et al., "Pharmacokinetics and Safety of AMD-3100, a Novel Antagonist of the CXCR-4 Chemokine Receptor, in Human Volunteers", Antimicrob. Agents Chemother., (20000601), vol. 44, no. 6, pages 1667 - 1673, XP055086299
OPPOSITION- DEVINE et al., "Rapid mobilization of functional donor hematopoietic cells without G-CSF using plerixafor, an antagonist of the CXCR4/SDF-1 interaction", Blood, (20080815), vol. 112, pages 990 - 998, XP055277466
OPPOSITION- HATTORI et al., "Plasma elevation of stromal cell-derived factor-1 induces mobilization of mature and immature hematopoietic progenitor and stem cells", Blood, (20010601), vol. 97, no. 11, pages 3354 - 3360, XP055699687
OPPOSITION- DEVINE et al., "Rapid Mobilization of CD34+ Cells Following Administration of the CXCR4 Antagonist AMD3100 to Patients With Multiple Myeloma and Non-Hodgkin's Lymphoma", Journal of Clinical Oncology, (20040223), vol. 22, no. 6, pages 1095 - 1102, XP055096637
OPPOSITION- FIGUEROA DB et al., "Discovery of genetic variants of the kinases that activate tenofovir among individuals in the United States , Thailand , and South Africa", PLoS One, (20180411), vol. 13, no. 4, page e0195764, XP055701577
OPPOSITION- GAZITT, "Immunologic Profiles of Effector Cells and Peripheral Blood Stem CellsMobilized with Different Hematopoietic Growth Factors", stem cells, (20001100), vol. 18, no. 6, pages 390 - 398, XP055701615
OPPOSITION- Yair Gazitt, "Immunologic Profiles of Effector Cells and Peripheral Blood Stem Cells Mobilized with Different Hematopoietic Growth Factors", STEM CELLS (MIAMISBURG), (20001101), vol. 18, no. 6, doi:10.1634/stemcells.18-6-390, ISSN 1066-5099, pages 390 - 398, XP055701615
OPPOSITION- GAZITT et al., "Plasma levels of SDF-1 and expression of SDF-1 receptor on CD 34+ cells in mobilized peripheral blood of non-hodgkin's lymphoma patients", Stem Cells, (20010000), vol. 19, doi:10.1634/stemcells.19-1-37, pages 37 - 45, XP055086524
OPPOSITION- GAZITT et al., Stem Cells., (20010000), vol. 19, pages 37 - 45, XP055086524
OPPOSITION- Yair Gazitt et al, "Plasma Levels of SDF-1 and Expression of SDF-1 Receptor on CD34 + Cells in Mobilized Peripheral Blood of Non-Hodgkin's Lymphoma Patients", Stem Cells, (20010101), vol. 19, no. 1, pages 37 - 45, XP055086524
OPPOSITION- ZIAREK et al., "Fragment-Based Optimization of Small Molecule CXCL12 Inhibitors for Antagonizing the CXCL12/CXCR4 Interaction", Current Topics in Medicinal Chemistry, (20120100), vol. 12, pages 2727 - 2740, XP055316604
OPPOSITION- SHEN et al., "CXCR-4 desensitization is associated with tissue localization of hemopoietic progenitor cells", J. Immunol., (20010000), vol. 166, doi:10.4049/jimmunol.166.8.5027, pages 5027 - 5033, XP055086511
OPPOSITION- SHEN et al., J. Immunol., (20010000), pages 5027 - 5033, XP055086511
OPPOSITION- SUZUKI et al., "Diverse Transcriptional Response of CD4+ T Cells to Stromal Cell-Derived Factor (SDF)-1: Cell Survival Promotion and Priming Effects of SDF-1 on CD4+ T Cells", Journal of Immunology, (20010915), vol. 167, no. 6, pages 3064 - 3073, XP055699709
SEARCH[ ] - ANONYM, "Clinical Results", BIOCENTURY, (20020715), vol. 10, no. 31(PT2), page B9
SEARCH[ ] - BLOOD, 43RD ANNUAL MEETING OF THE AMERICAN SOCIETY OF HEMATOLOGY, PART 1; ORLANDO, FLORIDA, USA; DECEMBER 07-11, 2001, (20011116), vol. 98, no. 11 Part 1, ISSN 0006-4971, page 737a
SEARCH[ ] - BLOOD, 43RD ANNUAL MEETING OF THE AMERICAN SOCIETY OF HEMATOLOGY, PART 1; ORLANDO, FLORIDA, USA; DECEMBER 07-11, 2001, (20011116), vol. 98, no. 11 Part 1, ISSN 0006-4971, page 811a
SEARCH- BROXMEYER HAL E ET AL, "Interference of the SDF-1/CXCR4 axis in mice with AMD3100 induces rapid high level mobilization of hematopoietic progenitor cells, and AMD3100 acts synergistically with G-CSF and MIP-1alpha to mobilize progenitors", BIOSIS, BIOSCIENCES INFORMATION SERVICE, PHILADELPHIA, PA, US, (20011116), Database accession no. PREV200200261505, XP002442331 [ADP] 1-12 * abstract *
SEARCH- BROXMEYER H ET AL, "AMD-3100, an antagonist of CXCR4, is a potent myeloid progenitor cell mobilizing agent in mouse strains differing in response to G-CSF-induced mobilization, and synergizes with G-CSF in these mice to enhance mobilization", EXPERIMENTAL HEMATOLOGY (CHARLOTTESVILLE), & 31ST ANNUAL MEETING OF THE INTERNATIONAL SOCIETY FOR EXPERIMENTAL HEMATOLOGY; MONTREAL, QUEBEC, CANADA; JULY 05-09, 2002, (200206), vol. 30, no. 6 Supplement 1, ISSN 0301-472X, page 45, XP002442327 [AP] 1-12 * abstract nr 34 *
SEARCH- CIN, URL: STN, XP002442333 [AP] 1-12 * abstract *
SEARCH- LARS OLE GERLACH, "Molecular interactions of cyclam and bicyclam non-peptide antagonists with the CXCR4 chemokine receptor", JOURNAL OF BIOLOGICAL CHEMISTRY, AMERICAN SOCIETY OF BIOLOCHEMICAL BIOLOGISTS, BIRMINGHAM,, US, (20010427), vol. 276, no. 17, ISSN 0021-9258, pages 14153 - 14160, XP002357019 [XD] 1-12 * the whole document *
SEARCH- LILES W CONRAD ET AL, "Leukocytosis and mobilization of pluripotent hematopoietic progenitor cells in healthy volunteers induced by single dose administration of AMD-3100, a CXCR4 antagonist", BIOSIS, BIOSCIENCES INFORMATION SERVICE, PHILADELPHIA, PA, US, (20011116), Database accession no. PREV200200250113, XP002442332 [ADP] 1-12 * abstract *
SEARCH- NAGASAWA T, "A chemokine, SDF-1/PBSF, and its receptor, CXC chemokine receptor 4, as mediators of hematopoiesis", INTERNATIONAL JOURNAL OF HEMATOLOGY, ELSEVIER SCIENCE PUBLISHERS, NL, (200012), vol. 72, no. 4, ISSN 0925-5710, pages 408 - 411, XP008081178 [A] 1-12 * the whole document *
SEARCH- VAN OS RONALD ET AL, "The CXCR4 receptor antagonist AMD3100 does not prevent homing and engraftment of murine syngeneic bone marrow stem cells", BLOOD, & 42ND ANNUAL MEETING OF THE AMERICAN SOCIETY OF HEMATOLOGY; SAN FRANCISCO, CALIFORNIA, USA; DECEMBER 01-05, 2000, (20001116), vol. 96, no. 11 Part 2, ISSN 0006-4971, page 308B, XP008081153 [X] 1-12 * abstract # 5074 *
SEARCH- QING MA ET AL, "The chemokine receptor CXCR4 is required for the retention of B lineage and granulocytic precursors within the bone marrow microenvironment", IMMUNITY 1999 UNITED STATES, (1999), vol. 10, no. 4, ISSN 1074-7613, pages 463 - 471, XP002453198 [A] 1-12 * the whole document *
SEARCH- AIUTI A ET AL, "THE CHEMOKINE SDF-1 IS A CHEMOATTRACTANT FOR HUMAN CD34+ HEMATOPOIETIC PROGENITOR CELLS AND PROVIDES A NEW MECHANISM TO EXPLAIN THE MOBILIZATION OF CD34+ PROGENITORS TO PERIPHERAL BLOOD", JOURNAL OF EXPERIMENTAL MEDICINE, TOKYO, JP, (1997), vol. 185, no. 1, ISSN 0022-1007, pages 111 - 120, XP000866066 [A] 1-12 * the whole document *
SEARCH- JACKSON K A ET AL, "Regeneration of ischemic cardiac muscle and vascular endothelium by adult stem cells", JOURNAL OF CLINICAL INVESTIGATION, NEW YORK, NY, US, (200106), vol. 107, no. 11, ISSN 0021-9738, pages 1395 - 1402, XP002976368 [A] 1-12 * the whole document *
SEARCH- VOERMANS C ET AL, "In vitro migratory capacity of CD34+ cells is related to hematopoietic recovery after autologous stem cell transplantation.", BLOOD 1 FEB 2001, (20010201), vol. 97, no. 3, ISSN 0006-4971, pages 799 - 804, XP002442326 [A] 1-12 * the whole document *

Download Citation Report

Get a free citation report including examiner, opposition, and international search citations.

Get Citation Report

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents